SecBot SecBot
8-K ·Filed Jul 22, 2026

SCLX

Scilex Holding Co
MIXED
Impact 5/10
Horizonweeks Processed3mo ago SEC0001193125-26-312591
Actionable Insight ◆ Mixed

Monitor receipt of the first $1M tranche and subsequent payments. The related-party nature and the company's broader capital needs (iHolding investment, Bitcoin purchase) suggest ongoing distress. Watch for any default on tranche payments or further dilutive financing.

DirectionMixed
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$7.39
T+0 close · Jul 22, 2026 · via day close
Latest settled
−61.84%
T+60 · $2.82
Vs SPY
−66.39%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 23 $7.39entry
  2. T+1 · 4mo ago −7.44%α −7.54% · $6.84
  3. T+5 · 4mo ago −10.69%α −11.17% · $6.60
  4. T+20 · 3mo ago −21.52%α −24.82% · $5.80
  5. T+60 · 5w ago −61.84%α −66.39% · $2.82
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Scilex Holding Co. completed the sale of its Vivasor preferred shares back to Vivasor for ~$12M, payable in five tranches through June 2027. The transaction provides near-term liquidity for a cash-strapped company but is a related-party deal (CEO Henry Ji leads both entities) and the proceeds are modest relative to Scilex's $67M market cap and going-concern risks. Combined with the pending $100M iHolding investment and the Bitcoin purchase agreement, this filing underscores ongoing financial distress and multiple capital-raising efforts.

Key Financial Metrics

Deal Value
$12.0M

Key Facts

  • Scilex sold 6,101,468 Series A-1 and 355,919 Series A-2 Vivasor preferred shares for $11,999,762.28 ($1.8583/share).
  • Payment is in five tranches: $999,980.97 on July 18, 2026; $4,999,901.10 by Sep 30, 2026; $1,999,960.07 by Dec 31, 2026; $1,999,960.07 by Mar 31, 2027; $1,999,960.07 by Jun 30, 2027.
  • Payment may be in cash or assignment of Datavault AI (DVLT) shares held by Vivasor's subsidiary.
  • Dr. Henry Ji, Scilex's CEO, is also CEO of Vivasor, a related-party transaction.
  • The shares were originally acquired by Scilex in January 2026.
  • Scilex has a going-concern audit opinion and a prior shelf registration, per cross-filing context.

Financial Impact

~$12M in cash or DVLT stock receivable over ~12 months, representing ~18% of Scilex's $67M market cap.

cashliquidityrelated-party exposure

Risk Factors

  • Related-party transaction risk, terms may not be at arm's length.
  • Tranche payment default risk, Vivasor may fail to make future payments.
  • Ongoing going-concern risk, Scilex's liquidity remains precarious despite this inflow.
  • Dilution risk from the pending Bitcoin purchase and iHolding investment.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 10 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (SCLX), Batch item 10001193125-26-312591
Document: sclx-20260718.htm0001193125-26-312591
Document: 0001193125-26-312591-index-headers.html0001193125-26-312591
Document: 0001193125-26-312591-index.html0001193125-26-312591
Document: 0001193125-26-312591.txt0001193125-26-312591
8-K Filing (SCLX), Batch item 60001193125-26-312591
Document: sclx-20260718.htm0001193125-26-312591
Document: 0001193125-26-312591-index-headers.html0001193125-26-312591
Document: 0001193125-26-312591-index.html0001193125-26-312591
Document: 0001193125-26-312591.txt0001193125-26-312591

Track record

11 reports on SCLX

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +34.62% at T+60 after the Jun 29, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Jul 22, 202616w ago 8-K Mixed 5/10 Viewing Entry $7.39 to $2.82 Now $1.25 −83.09% ▼ −61.84% −66.39% vs SPY
  2. Jul 6, 202619w ago 8-K Mixed 6/10 Entry $8.07 to $4.41 Now $1.25 −84.51% ▼ −45.35% −47.07% vs SPY
  3. Jun 29, 202620w ago 8-K Bearish 7/10 Entry $7.80 to $5.10 Now $1.25 +83.97% ▲ +34.62% +37.43% vs SPY
  4. Jun 12, 202622w ago Press Release Neutral 2/10 Entry $8.50 to $8.35 Now $1.25 −85.29% ▼ −1.75% −4.53% vs SPY
  5. Jun 12, 202622w ago EFFECT Bearish 6/10 Entry $8.50 to $8.35 Now $1.25 +85.29% ▲ +1.75% +4.53% vs SPY
  6. Jun 11, 202622w ago Institutional Cluster Neutral 2/10 Entry $8.70 to $8.62 Now $1.25 −85.63% ▼ −0.87% −4.69% vs SPY
  7. Jun 4, 202623w ago Press Release Neutral 4/10 Entry $4.72 to $5.43 Now $1.25 −73.52% ▲ +15.05% +13.17% vs SPY
  8. May 5, 202627w ago Press Release Bullish 8/10 Entry $6.68 to $6.60 Now $1.25 −81.29% ▼ −1.22% −3.96% vs SPY
  9. May 4, 202628w ago Press Release Neutral 4/10 Entry $6.94 to $6.56 Now $1.25 −82.00% ▼ −5.51% −7.37% vs SPY
  10. Apr 17, 202630w ago Insider Cluster Mixed 6/10 Entry $4.30 to $8.76 Now $1.25 −70.91% ▲ +103.89% +97.75% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens in 8h 47m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 22, 2026